New Jersey’s First Dual-Chamber Leadless Pacemakers Implanted at Jersey Shore University Medical Center
Aveir TM DR i2i clinical study studies synchronized two-chamber communication with minimally invasive implant procedure benefit
The cardiovascular team at Hackensack Meridian Jersey Shore University Medical Center recently implanted New Jersey’s first dual-chamber leadless pacemaker systems in patients, as part of Abbott’s Aveir TM DR i2i clinical study.
Electrophysiologist Mark Mascarenhas, M.D., implanted the first dual-chamber leadless pacemakers at Jersey Shore University Medical Center.
Leadless pacing options have been limited to single-chamber devices until now since synchronization of two leadless pacemakers has been highly difficult to achieve. Medical device company Abbott designed their i2i technology to provide beat-by-beat communication between two leadless pacemakers, one positioned in the right ventricle and one positioned in the right atrium of the heart. This technology is engineered to regulate the heart rate synchronously between chambers allowing for dual-chamber leadless pacing.
“This is incredibly significant as nearly 80 percent of people who receive a pacemaker need a dual-chamber option to pace both chambers on the right side of the heart,” said Dr. Mascarenhas. “While leadless pacemakers work like traditional pacemakers to regulate heart rate, they offer reduced lead-related complications and a less restrictive recovery period due to the minimally invasive implant procedure. This technology is a great enhancement in what we can provide to our patients with abnormal heart rhythms.”
Learn more about heart and vascular innovations at Jersey Shore University Medical Center.